LeMaitre Vascular, Inc. (LMAT): Price and Financial Metrics
LMAT Price/Volume Stats
Current price | $66.70 | 52-week high | $74.64 |
Prev. close | $66.84 | 52-week low | $44.27 |
Day low | $66.53 | Volume | 67,800 |
Day high | $67.71 | Avg. volume | 120,900 |
50-day MA | $61.33 | Dividend yield | 0.95% |
200-day MA | $58.31 | Market Cap | 1.49B |
LMAT Stock Price Chart Interactive Chart >
LMAT POWR Grades
- LMAT scores best on the Quality dimension, with a Quality rank ahead of 78.25% of US stocks.
- LMAT's strongest trending metric is Quality; it's been moving down over the last 26 weeks.
- LMAT ranks lowest in Momentum; there it ranks in the 4th percentile.
LMAT Stock Summary
- With a price/earnings ratio of 44.11, LEMAITRE VASCULAR INC P/E ratio is greater than that of about 83.84% of stocks in our set with positive earnings.
- Price to trailing twelve month operating cash flow for LMAT is currently 39.99, higher than 90.8% of US stocks with positive operating cash flow.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.15 for LEMAITRE VASCULAR INC; that's greater than it is for only 11.1% of US stocks.
- If you're looking for stocks that are quantitatively similar to LEMAITRE VASCULAR INC, a group of peers worth examining would be MMSI, AIN, NSSC, ATRI, and MOG.A.
- Visit LMAT's SEC page to see the company's official filings. To visit the company's web site, go to www.lemaitre.com.
LMAT Valuation Summary
- In comparison to the median Healthcare stock, LMAT's price/sales ratio is 209.09% higher, now standing at 6.8.
- Over the past 209 months, LMAT's price/sales ratio has gone up 3.9.
Below are key valuation metrics over time for LMAT.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
LMAT | 2023-12-29 | 6.8 | 4.4 | 46.3 | 35.1 |
LMAT | 2023-12-28 | 7.0 | 4.5 | 47.7 | 36.1 |
LMAT | 2023-12-27 | 6.9 | 4.4 | 47.1 | 35.7 |
LMAT | 2023-12-26 | 6.9 | 4.4 | 47.0 | 35.6 |
LMAT | 2023-12-22 | 6.8 | 4.4 | 46.5 | 35.2 |
LMAT | 2023-12-21 | 6.8 | 4.4 | 46.3 | 35.1 |
LMAT Growth Metrics
- Its year over year revenue growth rate is now at 17.38%.
- Its year over year net cashflow from operations growth rate is now at -14.98%.
- Its 5 year net income to common stockholders growth rate is now at 51.12%.
The table below shows LMAT's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 160.2 | 26.357 | 21.184 |
2022-06-30 | 159.54 | 33.09 | 22.232 |
2022-03-31 | 158.102 | 33.739 | 27.016 |
2021-12-31 | 154.424 | 35.102 | 26.907 |
2021-09-30 | 152.469 | 44.198 | 27.765 |
2021-06-30 | 150.517 | 44.235 | 28.774 |
LMAT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- LMAT has a Quality Grade of B, ranking ahead of 84.43% of graded US stocks.
- LMAT's asset turnover comes in at 0.589 -- ranking 73rd of 186 Medical Equipment stocks.
- ISRG, SYK, and KIDS are the stocks whose asset turnover ratios are most correlated with LMAT.
The table below shows LMAT's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.589 | 0.655 | 0.287 |
2021-06-30 | 0.597 | 0.649 | 0.299 |
2021-03-31 | 0.530 | 0.653 | 0.241 |
2020-12-31 | 0.542 | 0.654 | 0.220 |
2020-09-30 | 0.548 | 0.657 | 0.196 |
2020-06-30 | 0.574 | 0.677 | 0.177 |
LMAT Price Target
For more insight on analysts targets of LMAT, see our LMAT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $66.14 | Average Broker Recommendation | 1.5 (Moderate Buy) |
LeMaitre Vascular, Inc. (LMAT) Company Bio
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.
Latest LMAT News From Around the Web
Below are the latest news stories about LEMAITRE VASCULAR INC that investors may wish to consider to help them evaluate LMAT as an investment opportunity.
Insider Sell: Chairman and CEO George Lemaitre Sells 22,288 Shares of LeMaitre Vascular Inc (LMAT)George Lemaitre, the Chairman and CEO, as well as a 10% Owner of LeMaitre Vascular Inc (NASDAQ:LMAT), has recently sold 22,288 shares of the company's stock. |
LeMaitre Vascular Inc's CEO George Lemaitre Sells Shares: An Insider AnalysisGeorge Lemaitre, Chairman, CEO, and 10% Owner of LeMaitre Vascular Inc (NASDAQ:LMAT), has recently sold 50,995 shares of the company's stock on December 8, 2023. |
ESLOY or LMAT: Which Is the Better Value Stock Right Now?ESLOY vs. LMAT: Which Stock Is the Better Value Option? |
Sidoti Events, LLC's Virtual December Small-Cap ConferenceNEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December ... |
How Much Upside is Left in LeMaitre (LMAT)? Wall Street Analysts Think 25.24%The consensus price target hints at a 25.2% upside potential for LeMaitre (LMAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
LMAT Price Returns
1-mo | 6.89% |
3-mo | 21.90% |
6-mo | 17.56% |
1-year | 32.53% |
3-year | 43.57% |
5-year | 125.03% |
YTD | 17.80% |
2023 | 24.60% |
2022 | -7.40% |
2021 | 25.10% |
2020 | 14.09% |
2019 | 53.77% |
LMAT Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching LMAT
Here are a few links from around the web to help you further your research on Lemaitre Vascular Inc's stock as an investment opportunity:Lemaitre Vascular Inc (LMAT) Stock Price | Nasdaq
Lemaitre Vascular Inc (LMAT) Stock Quote, History and News - Yahoo Finance
Lemaitre Vascular Inc (LMAT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...